DONAFENIB: 37 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
37
Total FAERS Reports
6 (16.2%)
Deaths Reported
4
Hospitalizations
37
As Primary/Secondary Suspect
First Report: 20240405 · Latest Report: 20240804
What Are the Most Common DONAFENIB Side Effects?
#1 Most Reported
Therapy partial responder
21 reports (56.8%)
#2 Most Reported
Rash
6 reports (16.2%)
#3 Most Reported
Palmar-plantar erythrodysaesthesia syndrome
6 reports (16.2%)
All DONAFENIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Therapy partial responder | 21 | 56.8% | 0 | 0 |
| Diarrhoea | 6 | 16.2% | 0 | 1 |
| Palmar-plantar erythrodysaesthesia syndrome | 6 | 16.2% | 0 | 1 |
| Rash | 6 | 16.2% | 0 | 1 |
| Abdominal pain | 5 | 13.5% | 0 | 0 |
| Hypertension | 5 | 13.5% | 0 | 0 |
| Nausea | 5 | 13.5% | 0 | 0 |
| Pyrexia | 5 | 13.5% | 0 | 0 |
| Vomiting | 5 | 13.5% | 0 | 0 |
Who Reports DONAFENIB Side Effects? Age & Gender Data
Average age: 56.0 years. Most reports from: CN. View detailed demographics →
Is DONAFENIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2024 | 3 | 0 | 3 |
What Is DONAFENIB Used For?
| Indication | Reports |
|---|---|
| Hepatocellular carcinoma | 33 |
| Tumour thrombosis | 19 |
Official FDA Label for DONAFENIB
Official prescribing information from the FDA-approved drug label.